Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trial
- 30 October 2012
- Vol. 67 (12), 1090-1096
- https://doi.org/10.1136/thoraxjnl-2012-202178
Abstract
Background Continuous positive airway pressure (CPAP) for symptomatic obstructive sleep apnoea (OSA) improves sleepiness and reduces vascular risk, but such treatment for the more prevalent, minimally symptomatic disease is contentious. Methods This multicentre, randomised controlled, parallel, hospital-based trial across the UK and Canada, recruited 391 patients with confirmed OSA (oxygen desaturation index >7.5/h) but insufficient symptoms to warrant CPAP therapy. Patients were randomised to 6 months of auto-adjusting CPAP therapy, or standard care. Coprimary endpoints were change in Epworth Sleepiness Score (ESS) and predicted 5-year mortality using a cardiovascular risk score (components: age, sex, height, systolic blood pressure, smoking, diabetes, cholesterol, creatinine, left ventricular hypertrophy, previous myocardial infarction or stroke). Secondary endpoints included some of the individual components of the vascular risk score, objectively measured sleepiness and self-assessed health status. Results Of 391 patients randomised, 14 withdrew, 347 attended for their follow-up visit at 6 months within the predefined time window, of which 341 had complete ESS data (baseline mean 8.0, SD 4.3) and 310 had complete risk score data. 22% of patients in the CPAP group reported stopping treatment and overall median CPAP use was 2 : 39 h per night. CPAP significantly improved subjective daytime sleepiness (adjusted treatment effect on ESS −2.0 (95% CI −2.6 to −1.4), pConclusions In patients with minimally symptomatic OSA, CPAP can reduce subjective and objective daytime sleepiness, and improve self-assessed health status, but does not appear to improve calculated vascular risk.Keywords
This publication has 17 references indexed in Scilit:
- An economic analysis of continuous positive airway pressure for the treatment of obstructive sleep apnea-hypopnea syndromeInternational Journal of Technology Assessment in Health Care, 2009
- Effects of CPAP on oxidative stress and nitrate efficiency in sleep apnoea: a randomised trialThorax, 2008
- CPAP and measures of cardiovascular risk in males with OSASEuropean Respiratory Journal, 2008
- The impact of obstructive sleep apnea and daytime sleepiness on work limitationSleep Medicine, 2007
- Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patientsEuropean Respiratory Journal, 2006
- Most obstructive sleep apnoea patients exhibit vigilance and attention deficits on an extended battery of testsEuropean Respiratory Journal, 2005
- Sleep-Disordered Breathing, Glucose Intolerance, and Insulin Resistance: The Sleep Heart Health StudyAmerican Journal of Epidemiology, 2004
- Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trialsThorax, 2004
- Sleep disordered breathing may not be an independent risk factor for diabetes, but diabetes may contribute to the occurrence of periodic breathing in sleepSleep Medicine, 2003
- Obstructive sleep apnoea syndrome – an oxidative stress disorderSleep Medicine Reviews, 2003